Maximizing the impact of the Cures Acceleration Network [electronic resource] : accelerating the development of new drugs and diagnostics : workshop summary / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
2012
RM302 .I58 2012eb
Linked e-resources
Linked Resource
Online Access
Details
Title
Maximizing the impact of the Cures Acceleration Network [electronic resource] : accelerating the development of new drugs and diagnostics : workshop summary / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
Corporate Author
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, issuing body.
ISBN
9780309261166 paperback
0309261163 paperback
9780309261173 electronic book
0309261163 paperback
9780309261173 electronic book
Published
Washington, District of Columbia : National Academies Press, [2012]
Copyright
©2012
Language
English
Description
1 online resource (131 pages)
Call Number
RM302 .I58 2012eb
Dewey Decimal Classification
615.1/9
Summary
Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite these opportunities, only a small fraction of investigational products are successfully developed into cures and therapies that can be accessed by patients. One response to the ever-widening gap between the number and promise of basic scientific discoveries and the translation of those discoveries into therapies is a renewed emphasis on collaborative approaches among federal agencies, academia, and industry, all directed at the advancement of the drug development enterprise. The newly developed Cures Acceleration Network (CAN)-a part of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH)-has the potential to catalyze widespread changes in NCATS, NIH, and the drug development ecosystem in general. On June 4-5, 2012, the IOM Forum on Drug Discovery, Development, and Translation held, at the request of NCATS, a workshop-bringing together members of federal government agencies, the private sector, academia, and advocacy groups-to explore options and opportunities in the implementation of CAN. Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary summarizes the workshop."--Publisher's description.
Bibliography, etc. Note
Includes bibliographical references (pages 71).
Access Note
Access limited to authorized users.
Source of Description
Description based on print version record.
Added Corporate Author
National Institute of Medicine (U.S.). Board on Health Sciences Policy, issuing body.
Available in Other Form
Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary.
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
All Resources
Table of Contents
Introduction [The history and goals of CAN (Cures Acceleration Network)]
Approaches to accelerating translational science
Application of matching authority
Application of flexible research authority
Situating CAN within the drug development ecosystem
Final reflections on ways to maximize the goals of CAN.
Approaches to accelerating translational science
Application of matching authority
Application of flexible research authority
Situating CAN within the drug development ecosystem
Final reflections on ways to maximize the goals of CAN.